Revolutionizing MedTech for a Better Tomorrow
BioXcyte
At BioXcyte, we are transforming the landscape of healthcare diagnostics through cutting-edge point-of-care solutions. Our mission is to empower clinicians and patients with rapid, accurate, and accessible diagnostic tools that bridge the gap between early detection and timely intervention.
WHO WE ARE: A Singapore-MIT spin-off led by scientists, engineers and clinicians in the field of microfluidics, clinical immunology, and AI diagnostics.
 |  |  |  |  |  |  |  |  |
|---|---|---|---|---|---|---|---|---|
 |  |
The Problem
Our immune cells responds and guards against various health threats such as infection, cancer and chronic diseases. Yet, there is a lack of rapid bedside test for immune cell response to guide clinical diagnosis and therapy.
Our Solution
A rapid bedside test for immune cells at point-of-care with a drop of blood is a game changer.